3Califf RM,Cohn JN.Cardiac protection:evolite role of angiotension receptor blockers[J].Am Heart J,2000,139:S15-S22.
4Gillis JC, Markhan A. Irbesartan, a review of its pharmacodynamic and pharmacokinetic propertics and therapeutic use in the menagement of hypertention. [J]. Drug, 1997,54(4) :885 - 902.
5Kassler-Taub K, Littlejohn T, Elliottw W, et al. Comparative effective of two angiotensin Ⅱ receptor antagoniats, irbesartan and losartan[J ]. Am J Hypertens, 1998,11 (2) :445 - 453.
6Lewis EJ,Hunsicker LG,Clarke WR,etal. Renoprotective effect of the angiotensin-receptor antagost irbesartan in patients with nephropathy due to type 2 diabetes. [J].N Engl Med, 2001,345(12):851 - 860.
7Schmieder RE, Langenfeld, MRW, Friedrich A, et al. Angiotensin Ⅱ related to sodium excretion modulates left w.'ntricular structure in human essential hypertension [ J ]. Circulation, 1996,94 ( 10 ) :1732- 1738.
8Sudoh T,Kangawa K,Minamion N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332(6159):78
9Kohno M,Horio T,Yokokawa K,et al.Brain natriuretic peptide as a cardiac hormone in essential hypertension[J].Am J Med,1992,92(1):29
10Gheorghiade M,Bonow RO.Chronic heart failure in the United States:a manifestation of coronary artery disease[J].Circulation,1988,97(3):282
